138 related articles for article (PubMed ID: 16691193)
21. BRAF mutational epidemiology in dysplastic nevi: does different solar UV radiation exposure matter?
Saroufim M; Novy M; Taraif S; Habib RH; Loya A; Rauscher B; Kriegshäuser G; Oberkanins C; Khalifeh I
J Eur Acad Dermatol Venereol; 2014 May; 28(5):615-25. PubMed ID: 23906414
[TBL] [Abstract][Full Text] [Related]
22. BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients.
Kanitakis J; Baldassini S; Lora V; Euvrard S
Eur J Dermatol; 2010; 20(2):167-71. PubMed ID: 19919912
[TBL] [Abstract][Full Text] [Related]
23. High frequency of BRAF mutations in nevi.
Pollock PM; Harper UL; Hansen KS; Yudt LM; Stark M; Robbins CM; Moses TY; Hostetter G; Wagner U; Kakareka J; Salem G; Pohida T; Heenan P; Duray P; Kallioniemi O; Hayward NK; Trent JM; Meltzer PS
Nat Genet; 2003 Jan; 33(1):19-20. PubMed ID: 12447372
[TBL] [Abstract][Full Text] [Related]
24. Genetic alterations in melanocytic tumors.
Takata M; Saida T
J Dermatol Sci; 2006 Jul; 43(1):1-10. PubMed ID: 16750612
[TBL] [Abstract][Full Text] [Related]
25. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi.
Uribe P; Andrade L; Gonzalez S
J Invest Dermatol; 2006 Jan; 126(1):161-6. PubMed ID: 16417232
[TBL] [Abstract][Full Text] [Related]
26. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites.
Cohen Y; Rosenbaum E; Begum S; Goldenberg D; Esche C; Lavie O; Sidransky D; Westra WH
Clin Cancer Res; 2004 May; 10(10):3444-7. PubMed ID: 15161700
[TBL] [Abstract][Full Text] [Related]
27. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
[TBL] [Abstract][Full Text] [Related]
28. Mutations of the BRAF gene in benign and malignant melanocytic lesions.
Yazdi AS; Palmedo G; Flaig MJ; Puchta U; Reckwerth A; Rütten A; Mentzel T; Hügel H; Hantschke M; Schmid-Wendtner MH; Kutzner H; Sander CA
J Invest Dermatol; 2003 Nov; 121(5):1160-2. PubMed ID: 14708620
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions?
Decarlo K; Yang S; Emley A; Wajapeyee N; Green M; Mahalingam M
Hum Pathol; 2010 Jun; 41(6):886-94. PubMed ID: 20233623
[TBL] [Abstract][Full Text] [Related]
30. Molecular Genomic Profiling of Melanocytic Nevi.
Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
[TBL] [Abstract][Full Text] [Related]
31. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
Dadzie OE; Yang S; Emley A; Keady M; Bhawan J; Mahalingam M
Br J Dermatol; 2009 Feb; 160(2):368-75. PubMed ID: 18945298
[TBL] [Abstract][Full Text] [Related]
32. A Mutational Survey of Acral Nevi.
Smalley KSM; Teer JK; Chen YA; Wu JY; Yao J; Koomen JM; Chen WS; Rodriguez-Waitkus P; Karreth FA; Messina JL
JAMA Dermatol; 2021 Jul; 157(7):831-835. PubMed ID: 33978681
[TBL] [Abstract][Full Text] [Related]
33. BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han.
Qi RQ; He L; Zheng S; Hong Y; Ma L; Zhang S; Zhao L; Guo X; Wang Y; Yu JY; Fu L; Zhang W; Long T; Zhang C; Chen G; Lin J; Wang C; Zhou L; Mi Q; Weiland M; Chen JZ; McHenga SS; Wang YK; McHepange U; Wang Z; Chen HD; Gao XH
J Invest Dermatol; 2011 May; 131(5):1129-38. PubMed ID: 21326296
[TBL] [Abstract][Full Text] [Related]
34. Differential gene expression in melanocytic nevi with the V600E BRAF mutation.
Bloethner S; Snellman E; Bermejo JL; Hiripi E; Gast A; Thirumaran RK; Wellenreuther R; Hemminki K; Kumar R
Genes Chromosomes Cancer; 2007 Nov; 46(11):1019-27. PubMed ID: 17696195
[TBL] [Abstract][Full Text] [Related]
35. What dermoscopy tells us about nevogenesis.
Zalaudek I; Catricalà C; Moscarella E; Argenziano G
J Dermatol; 2011 Jan; 38(1):16-24. PubMed ID: 21175751
[TBL] [Abstract][Full Text] [Related]
36. The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations.
Zalaudek I; Guelly C; Pellacani G; Hofmann-Wellenhof R; Trajanoski S; Kittler H; Scope A; Marghoob AA; Longo C; Leinweber B; Ferrara G; Saida T; Grichnik JM; Argenziano G; Becker JC
J Invest Dermatol; 2011 Feb; 131(2):542-5. PubMed ID: 21068756
[No Abstract] [Full Text] [Related]
37. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
[TBL] [Abstract][Full Text] [Related]
38. BRAFE600-associated senescence-like cell cycle arrest of human naevi.
Michaloglou C; Vredeveld LC; Soengas MS; Denoyelle C; Kuilman T; van der Horst CM; Majoor DM; Shay JW; Mooi WJ; Peeper DS
Nature; 2005 Aug; 436(7051):720-4. PubMed ID: 16079850
[TBL] [Abstract][Full Text] [Related]
39. Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.
Dessars B; De Raeve LE; El Housni H; Debouck CJ; Sidon PJ; Morandini R; Roseeuw D; Ghanem GE; Vassart G; Heimann P
J Invest Dermatol; 2007 Jun; 127(6):1468-70. PubMed ID: 17301836
[TBL] [Abstract][Full Text] [Related]
40. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.
Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT
Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
